SG11201505352RA - Controlled release formulations of lorazepam - Google Patents
Controlled release formulations of lorazepamInfo
- Publication number
- SG11201505352RA SG11201505352RA SG11201505352RA SG11201505352RA SG11201505352RA SG 11201505352R A SG11201505352R A SG 11201505352RA SG 11201505352R A SG11201505352R A SG 11201505352RA SG 11201505352R A SG11201505352R A SG 11201505352RA SG 11201505352R A SG11201505352R A SG 11201505352RA
- Authority
- SG
- Singapore
- Prior art keywords
- lorazepam
- controlled release
- release formulations
- formulations
- controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361750792P | 2013-01-09 | 2013-01-09 | |
| US201361762836P | 2013-02-08 | 2013-02-08 | |
| PCT/US2014/010863 WO2014110248A1 (en) | 2013-01-09 | 2014-01-09 | Controlled release formulations of lorazepam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505352RA true SG11201505352RA (en) | 2015-08-28 |
Family
ID=50030512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505352RA SG11201505352RA (en) | 2013-01-09 | 2014-01-09 | Controlled release formulations of lorazepam |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP2943186A1 (pt) |
| JP (1) | JP2016504391A (pt) |
| KR (1) | KR20150127037A (pt) |
| CN (1) | CN105188682A (pt) |
| AU (1) | AU2014205356A1 (pt) |
| BR (1) | BR112015016322A8 (pt) |
| CA (1) | CA2897313A1 (pt) |
| CL (1) | CL2015001921A1 (pt) |
| HK (1) | HK1213803A1 (pt) |
| IL (1) | IL239778A0 (pt) |
| MX (1) | MX2015008757A (pt) |
| PE (1) | PE20151431A1 (pt) |
| PH (1) | PH12015501533A1 (pt) |
| RU (1) | RU2015128914A (pt) |
| SG (1) | SG11201505352RA (pt) |
| WO (1) | WO2014110248A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7110366B2 (ja) | 2017-11-01 | 2022-08-01 | エッジモント・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニー・トラスト | ロラゼパムのアルコール耐性経口用医薬組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL298071A (pt) | 1963-06-04 | |||
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3786813A (en) | 1972-12-27 | 1974-01-22 | Alza Corp | Drug delivery device with self actuated mechanism for retaining device in selected area |
| US4361545A (en) | 1979-05-21 | 1982-11-30 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion |
| JPS61501511A (ja) * | 1984-03-21 | 1986-07-24 | アメリカン・ホ−ム・プロダクツ・コ−ポレイション | 徐放性医薬カプセル |
| US4624847A (en) | 1985-04-22 | 1986-11-25 | Alza Corporation | Drug delivery device for programmed delivery of beneficial drug |
| US5009895A (en) | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
| US5945125A (en) | 1995-02-28 | 1999-08-31 | Temple University | Controlled release tablet |
| CO5140079A1 (es) * | 1998-10-14 | 2002-03-22 | Novartis Ag | Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo |
| CA2431205C (en) | 2000-12-05 | 2005-08-23 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
| EP1414416A4 (en) | 2001-07-10 | 2007-06-27 | Teva Pharma | DRUG DELIVERY SYSTEM FOR RISING OR DECLINING MEDICINAL PRODUCT LEAVES OR BIPHASIC ZERO ORDER |
| US6703045B2 (en) | 2001-08-21 | 2004-03-09 | Council Of Scientific & Industrial Research | Composition and method for maintaining blood glucose level |
| BR0302017B1 (pt) * | 2003-06-02 | 2014-10-29 | Ems Sigma Pharma Ltda | Composição farmacêutica sublingual a base de um agonista do receptor central de benzodiazepínicos |
| WO2006088305A1 (en) * | 2005-02-15 | 2006-08-24 | Chong Kun Dang Pharmaceutical Corp. | Gastric-retentive controlled release mono-matrix tablet |
-
2014
- 2014-01-09 BR BR112015016322A patent/BR112015016322A8/pt active Search and Examination
- 2014-01-09 RU RU2015128914A patent/RU2015128914A/ru unknown
- 2014-01-09 EP EP14702134.9A patent/EP2943186A1/en not_active Withdrawn
- 2014-01-09 JP JP2015551871A patent/JP2016504391A/ja active Pending
- 2014-01-09 WO PCT/US2014/010863 patent/WO2014110248A1/en active Application Filing
- 2014-01-09 PE PE2015001249A patent/PE20151431A1/es not_active Application Discontinuation
- 2014-01-09 KR KR1020157020972A patent/KR20150127037A/ko not_active Application Discontinuation
- 2014-01-09 MX MX2015008757A patent/MX2015008757A/es unknown
- 2014-01-09 AU AU2014205356A patent/AU2014205356A1/en not_active Abandoned
- 2014-01-09 SG SG11201505352RA patent/SG11201505352RA/en unknown
- 2014-01-09 CN CN201480012337.2A patent/CN105188682A/zh active Pending
- 2014-01-09 CA CA2897313A patent/CA2897313A1/en not_active Abandoned
-
2015
- 2015-07-05 IL IL239778A patent/IL239778A0/en unknown
- 2015-07-06 CL CL2015001921A patent/CL2015001921A1/es unknown
- 2015-07-07 PH PH12015501533A patent/PH12015501533A1/en unknown
-
2016
- 2016-02-19 HK HK16101886.7A patent/HK1213803A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105188682A (zh) | 2015-12-23 |
| IL239778A0 (en) | 2015-08-31 |
| AU2014205356A1 (en) | 2015-07-30 |
| CA2897313A1 (en) | 2014-07-17 |
| MX2015008757A (es) | 2016-02-05 |
| WO2014110248A1 (en) | 2014-07-17 |
| CL2015001921A1 (es) | 2015-12-18 |
| EP2943186A1 (en) | 2015-11-18 |
| PE20151431A1 (es) | 2015-09-23 |
| JP2016504391A (ja) | 2016-02-12 |
| BR112015016322A2 (pt) | 2017-07-11 |
| PH12015501533A1 (en) | 2015-10-05 |
| HK1213803A1 (zh) | 2016-07-15 |
| RU2015128914A (ru) | 2017-02-14 |
| BR112015016322A8 (pt) | 2018-01-23 |
| KR20150127037A (ko) | 2015-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280485A (en) | Sustained-release pridopidine preparations | |
| IL287516A (en) | Medicinal uses of empagliflozin | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| HK1213818A1 (zh) | 依帕列淨的治療用途 | |
| EP2991639A4 (en) | PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE | |
| HK1221416A1 (zh) | 氧雜雙環庚烷和氧雜雙環庚烯的配製品 | |
| LT2981271T (lt) | Empagliflozino terapinis panaudojimas | |
| HK1216839A1 (zh) | 調整釋放製劑 | |
| EP2988595A4 (en) | Gel formulations for the prolonged release of volatile compounds | |
| ZA201505830B (en) | Formulations of organc compounds | |
| HK1213770A1 (zh) | 勞拉西泮的緩釋製劑 | |
| HK1213803A1 (zh) | 勞拉西泮的控釋製劑 | |
| PL3071575T3 (pl) | Wytwarzanie normorfinanów |